BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mura P. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review. Int J Pharm 2020;579:119181. [PMID: 32112928 DOI: 10.1016/j.ijpharm.2020.119181] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen C, Banh K, Dang C, Nguyen C, Nguyen T. β-cyclodextrin/alginate nanoparticles encapsulated 5-fluorouracil as an effective and safe anticancer drug delivery system. Arabian Journal of Chemistry 2022;15:103814. [DOI: 10.1016/j.arabjc.2022.103814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lucia Appleton S, Navarro-Orcajada S, Martínez-Navarro FJ, Caldera F, López-Nicolás JM, Trotta F, Matencio A. Cyclodextrins as Anti-inflammatory Agents: Basis, Drugs and Perspectives. Biomolecules 2021;11:1384. [PMID: 34572597 DOI: 10.3390/biom11091384] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mutingwende FP, Kondiah PPD, Ubanako P, Marimuthu T, Choonara YE. Advances in Nano-Enabled Platforms for the Treatment of Depression. Polymers (Basel) 2021;13:1431. [PMID: 33946703 DOI: 10.3390/polym13091431] [Reference Citation Analysis]
4 Abdelnabi H, Alshaer W, Azzam H, Alqudah D, Al-Samydai A, Aburjai T. Loading of capsaicin-in-cyclodextrin inclusion complexes into PEGylated liposomes and the inhibitory effect on IL-8 production by MDA-MB-231 and A549 cancer cell lines. Z Naturforsch C J Biosci 2021. [PMID: 34036759 DOI: 10.1515/znc-2021-0018] [Reference Citation Analysis]
5 Yan Y, Zhao X, Wang C, Fang Q, Zhong L, Wei Q. Preparation, Optimization, and Characterization of Inclusion Complexes of Cinnamomum longepaniculatum Essential Oil in β-Cyclodextrin. Sustainability 2022;14:9513. [DOI: 10.3390/su14159513] [Reference Citation Analysis]
6 Rassu G, Sorrenti M, Catenacci L, Pavan B, Ferraro L, Gavini E, Bonferoni MC, Giunchedi P, Dalpiaz A. Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives? Pharmaceutics 2021;13:1180. [PMID: 34452141 DOI: 10.3390/pharmaceutics13081180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Corsaro C, Mallamace D, Neri G, Fazio E. Hydrophilicity and hydrophobicity: Key aspects for biomedical and technological purposes. Physica A: Statistical Mechanics and its Applications 2021;580:126189. [DOI: 10.1016/j.physa.2021.126189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Togami K, Ogasawara A, Irie S, Iwata K, Yamaguchi K, Tada H, Chono S. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib–hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.02.009] [Reference Citation Analysis]
9 Lv S, Zhang X, Feng Y, Jiang Q, Niu C, Yang Y, Wang X. Gut Microbiota Combined With Metabolomics Reveals the Repeated Dose Oral Toxicity of β-Cyclodextrin in Mice. Front Pharmacol 2020;11:574607. [PMID: 33519440 DOI: 10.3389/fphar.2020.574607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cheng G, Luo J, Liu Y, Chen X, Wu Z, Chen T. Cucurbituril-Oriented Nanoplatforms in Biomedical Applications. ACS Appl Bio Mater 2020;3:8211-40. [PMID: 35019600 DOI: 10.1021/acsabm.0c01061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Carvalho RM, Rosa IGL, Gomes DEB, Goliatt PVZC, Goliatt L. Gaussian processes regression for cyclodextrin host-guest binding prediction. J Incl Phenom Macrocycl Chem 2021;101:149-59. [DOI: 10.1007/s10847-021-01092-4] [Reference Citation Analysis]
12 Bouattour Y, Neflot-Bissuel F, Traïkia M, Biesse-Martin AS, Frederic R, Yessaad M, Jouannet M, Wasiak M, Chennell P, Sautou V. Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis. Int J Mol Sci 2021;22:10538. [PMID: 34638878 DOI: 10.3390/ijms221910538] [Reference Citation Analysis]
13 Meiczinger M, Varga B, Wolmarans L, Hajba L, Somogyi V. Stability improvement of laccase for micropollutant removal of pharmaceutical origins from municipal wastewater. Clean Techn Environ Policy. [DOI: 10.1007/s10098-022-02336-8] [Reference Citation Analysis]
14 Jiang G, Jia H, Qiu J, Mo Z, Wen Y, Zhang Y, Wen Y, Xie Q, Ban J, Lu Z, Chen Y, Wu H, Ni Q, Chen F, Lu J, Wang Z, Li H, Chen J. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers. Int J Nanomedicine 2020;15:9373-87. [PMID: 33262593 DOI: 10.2147/IJN.S272750] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Ji H, Bai Y, Liu Y, Wang Y, Zhan X, Long J, Chen L, Qiu C, Jin Z. Deciphering external chain length and cyclodextrin production with starch catalyzed by cyclodextrin glycosyltransferase. Carbohydrate Polymers 2022;284:119156. [DOI: 10.1016/j.carbpol.2022.119156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Donalisio M, Argenziano M, Rittà M, Bastiancich C, Civra A, Lembo D, Cavalli R. Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections. International Journal of Pharmaceutics 2020;587:119676. [DOI: 10.1016/j.ijpharm.2020.119676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Kim JM, Kim J, Ha M, Nam JM. Cyclodextrin-Based Synthesis and Host-Guest Chemistry of Plasmonic Nanogap Particles with Strong, Quantitative, and Highly Multiplexable Surface-Enhanced Raman Scattering Signals. J Phys Chem Lett 2020;11:8358-64. [PMID: 32956585 DOI: 10.1021/acs.jpclett.0c02624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Real DA, Bolaños K, Priotti J, Yutronic N, Kogan MJ, Sierpe R, Donoso-González O. Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability. Pharmaceutics 2021;13:2131. [PMID: 34959412 DOI: 10.3390/pharmaceutics13122131] [Reference Citation Analysis]
19 Wu Y, Wan S, Chen Y, Fan J, Li Y, Wang T, Yuan Z, Yang Q, Qin H, Xu J, Zhang J. Biomimetic lipidic nanovectors for effective asparaginase supramolecule delivery. Nanomedicine 2022;41:102518. [PMID: 35032628 DOI: 10.1016/j.nano.2022.102518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mirzaeinia S, Zeinali S, Budisa N, Karbalaei-heidari HR. Targeted Codelivery of Prodigiosin and Simvastatin Using Smart BioMOF: Functionalization by Recombinant Anti-VEGFR1 scFv. Front Bioeng Biotechnol 2022;10:866275. [DOI: 10.3389/fbioe.2022.866275] [Reference Citation Analysis]
21 Jansook P, Loftsson T. Self-assembled γ-cyclodextrin as nanocarriers for enhanced ocular drug bioavailability. International Journal of Pharmaceutics 2022;618:121654. [DOI: 10.1016/j.ijpharm.2022.121654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Costa M, Sezgin-Bayindir Z, Losada-Barreiro S, Paiva-Martins F, Saso L, Bravo-Díaz C. Polyphenols as Antioxidants for Extending Food Shelf-Life and in the Prevention of Health Diseases: Encapsulation and Interfacial Phenomena. Biomedicines 2021;9:1909. [PMID: 34944722 DOI: 10.3390/biomedicines9121909] [Reference Citation Analysis]
23 Trucillo P, Sofia D, Cortese L, Urciuolo M. Production of Q10+B2 nanostructured lipid carriers and optimization of their entrapment capacities. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112653] [Reference Citation Analysis]
24 Kucuksayan E, Bozkurt F, Yilmaz MT, Sircan-Kucuksayan A, Hanikoglu A, Ozben T. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers. Sci Rep 2021;11:13027. [PMID: 34158544 DOI: 10.1038/s41598-021-92447-x] [Reference Citation Analysis]
25 Poulson BG, Alsulami QA, Sharfalddin A, El Agammy EF, Mouffouk F, Emwas A, Jaremko L, Jaremko M. Cyclodextrins: Structural, Chemical, and Physical Properties, and Applications. Polysaccharides 2022;3:1-31. [DOI: 10.3390/polysaccharides3010001] [Reference Citation Analysis]
26 Loftsson T. Cyclodextrins in Parenteral Formulations. J Pharm Sci 2021;110:654-64. [PMID: 33069709 DOI: 10.1016/j.xphs.2020.10.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
27 Takke A, Shende P. Potential of cyclodextrin in hybrid liposomes for improving the solubility, bioavailability and stability of silibinin. Chem Pap . [DOI: 10.1007/s11696-022-02345-3] [Reference Citation Analysis]